Solventum Corp. SOLV

What this company does

Solventum Corporation develops, manufactures, and commercializes healthcare solutions that draw on material science, data science, and digital capabilities. It sells its products in more than 90 countries. It employed approximately 20,000 people, including about 10,000 in the United States and about 2,000 in Germany. It is organized into three reportable operating business segments aligned with the markets it serves. Its MedSurg segment, which accounted for 57.9% of 2025 total sales, provides negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, and medical electrodes. Its Dental Solutions segment, which accounted for 16.2% of 2025 total sales, provides dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. Its Health Information Systems segment, which accounted for 16.3% of 2025 total sales, provides healthcare systems with software solutions including computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms.

Written from the business description in SOLVENTUM CORPORATION's annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.